These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

978 related items for PubMed ID: 22578915

  • 1. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M, Matthis C, Eggers J.
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [Abstract] [Full Text] [Related]

  • 2. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A, Epstein D, Cohen D, Bathula R, Devine J, Kar A, Taube D, Duncan N, Ames D.
    Cerebrovasc Dis; 2013 Jan; 35(1):45-52. PubMed ID: 23428996
    [Abstract] [Full Text] [Related]

  • 3. Risk of thrombolytic therapy for acute ischemic stroke in patients with current malignancy.
    Masrur S, Abdullah AR, Smith EE, Hidalgo R, El-Ghandour A, Rordorf G, Schwamm LH.
    J Stroke Cerebrovasc Dis; 2011 Jan; 20(2):124-30. PubMed ID: 20598579
    [Abstract] [Full Text] [Related]

  • 4. Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.
    Seet RC, Rabinstein AA.
    Cerebrovasc Dis; 2012 Jan; 34(2):106-14. PubMed ID: 22868870
    [Abstract] [Full Text] [Related]

  • 5. Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials.
    Martí-Fàbregas J, Bravo Y, Cocho D, Martí-Vilalta JL, Díaz-Manera J, San Román L, Puig M, Blanco M, Castellanos M, Millán M, Roquer J, Obach V, Maestre J.
    Cerebrovasc Dis; 2007 Jan; 23(2-3):85-90. PubMed ID: 17114877
    [Abstract] [Full Text] [Related]

  • 6. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M, Naganuma M, Okada Y, Hasegawa Y, Shiokawa Y, Nakagawara J, Furui E, Kimura K, Yamagami H, Kario K, Okuda S, Koga M, Minematsu K, Toyoda K.
    Cerebrovasc Dis; 2012 Jan; 34(2):140-6. PubMed ID: 22854333
    [Abstract] [Full Text] [Related]

  • 7. Intravenous thrombolysis with rt-PA in acute ischemic stroke patients aged older than 80 years in Italy.
    Toni D, Lorenzano S, Agnelli G, Guidetti D, Orlandi G, Semplicini A, Toso V, Caso V, Malferrari G, Fanucchi S, Bartolomei L, Prencipe M.
    Cerebrovasc Dis; 2008 Jan; 25(1-2):129-35. PubMed ID: 18073466
    [Abstract] [Full Text] [Related]

  • 8. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC, Gupta R, Smith WS, Kamel H, Faigeles BS, Cullen SP, Rao VA, Bath PM, Wahlgren N, Ahmed N, Donnan GA, SITS International and VISTA-plus investigators.
    Int J Stroke; 2014 Aug; 9(6):705-10. PubMed ID: 25042855
    [Abstract] [Full Text] [Related]

  • 9. Predictors of in-hospital death and symptomatic intracranial hemorrhage in patients with acute ischemic stroke treated with thrombolytic therapy: Paul Coverdell Acute Stroke Registry 2008-2012.
    Tong X, George MG, Yang Q, Gillespie C.
    Int J Stroke; 2014 Aug; 9(6):728-34. PubMed ID: 24024962
    [Abstract] [Full Text] [Related]

  • 10. Safety and outcomes following thrombolytic treatment in stroke patients who had received prior treatment with anticoagulants.
    Matute MC, Masjuan J, Egido JA, Fuentes B, Simal P, Díaz-Otero F, Reig G, Díez-Tejedor E, Gil-Nuñez A, Vivancos J, Alonso de Leciñana M.
    Cerebrovasc Dis; 2012 Aug; 33(3):231-9. PubMed ID: 22261670
    [Abstract] [Full Text] [Related]

  • 11. Is there a decreased risk of intracerebral hemorrhage and mortality in obese patients treated with intravenous thrombolysis in acute ischemic stroke?
    Hassan AE, Chaudhry SA, Jani V, Grigoryan M, Khan AA, Adil MM, Qureshi AI.
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):545-9. PubMed ID: 23453555
    [Abstract] [Full Text] [Related]

  • 12. TPA for ischemic stroke in patients ≥80 years.
    Henriksen EH, Ljøstad U, Tveiten A, Naess H, Thomassen L, Mygland A.
    Acta Neurol Scand; 2013 May; 127(5):309-15. PubMed ID: 22988960
    [Abstract] [Full Text] [Related]

  • 13. The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis.
    Sobesky J, Frackowiak M, Zaro Weber O, Hahn M, Möller-Hartmann W, Rudolf J, Neveling M, Grond M, Schmulling S, Jacobs A, Heiss WD.
    Cerebrovasc Dis; 2007 May; 24(1):56-65. PubMed ID: 17519545
    [Abstract] [Full Text] [Related]

  • 14. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
    Hermann A, Dzialowski I, Koch R, Gahn G.
    J Neurol Sci; 2009 Sep 15; 284(1-2):155-7. PubMed ID: 19473668
    [Abstract] [Full Text] [Related]

  • 15. Race/Ethnic differences in the risk of hemorrhagic complications among patients with ischemic stroke receiving thrombolytic therapy.
    Mehta RH, Cox M, Smith EE, Xian Y, Bhatt DL, Fonarow GC, Peterson ED, Get With The Guidelines-Stroke Program.
    Stroke; 2014 Aug 15; 45(8):2263-9. PubMed ID: 25070958
    [Abstract] [Full Text] [Related]

  • 16. Safety of a "drip and ship" intravenous thrombolysis protocol for patients with acute ischemic stroke.
    Mansoor S, Zand R, Al-Wafai A, Wahba MN, Giraldo EA.
    J Stroke Cerebrovasc Dis; 2013 Oct 15; 22(7):969-71. PubMed ID: 22306381
    [Abstract] [Full Text] [Related]

  • 17. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.
    J Stroke Cerebrovasc Dis; 2013 Apr 15; 22(3):190-6. PubMed ID: 21968092
    [Abstract] [Full Text] [Related]

  • 18. Factors predicting outcome in stroke patients treated with 0.6 mg/kg alteplase: evidence from the Japan Alteplase Clinical Trial (J-ACT).
    Mori E, Minematsu K, Nakagawara J, Yamaguchi T, Japan Alteplase Clinical Trial (J-ACT) Group.
    J Stroke Cerebrovasc Dis; 2011 Nov 15; 20(6):517-22. PubMed ID: 20719535
    [Abstract] [Full Text] [Related]

  • 19. Lipid profile, lipid-lowering medications, and intracerebral hemorrhage after tPA in get with the guidelines-stroke.
    Messé SR, Pervez MA, Smith EE, Siddique KA, Hellkamp AS, Saver JL, Bhatt DL, Fonarow GC, Peterson ED, Schwamm LH.
    Stroke; 2013 May 15; 44(5):1354-9. PubMed ID: 23493734
    [Abstract] [Full Text] [Related]

  • 20. A model to prevent fibrinolysis in patients with stroke mimics.
    Chang J, Teleb M, Yang JP, Alderazi YJ, Chapple K, Frey JL, Restrepo L.
    J Stroke Cerebrovasc Dis; 2012 Nov 15; 21(8):839-43. PubMed ID: 21640609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.